Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition with immune dysfunction that affects lesional and nonlesional skin.1 Characterized by pruritus, skin pain, eczematous lesions and dry skin, AD is associated with substantial comorbidity and impairment in a patient’s quality-o

As suggested by the observational studies from Italy and France presented at the Virtual Annual Congress of the European Academy of Dermatology and Venereology, biologic therapy for psoriasis may be protective to infected patients against severe and fatal COVID-19 although such protective benefit do

Metastatic melanoma is an aggressive form of skin cancer with poor prognosis. Targeted therapies such as BRAF and MEK inhibitors have demonstrated clinical benefits in patients with advanced BRAF-mutant melanoma.^1,2